OBJECTIVE: Subjects with decreased erythrocyte survival have an unusually low GHb percentage. The goal of this study was to determine whether hyperglycemia, as reflected by GHb percentage, is associated with decreased erythrocyte survival. RESEARCH DESIGN AND METHODS: Erythrocyte survival was quantitated in 23 subjects with type 2 diabetes, and these values were correlated with the subjects' GHb percentage. Erythrocyte survival was determined from the difference between the subjects' alveolar carbon monoxide (CO) concentration and atmospheric CO concentration. Reticulocyte counts were obtained in 16 subjects. RESULTS: Although the vast majority of the subjects had erythrocyte life spans that fell within the normal range (123 +/- 23 days), there was a highly significant inverse correlation (r = -0.66, P < 0.01) between life span and GHb percentage, with an average decline in life span of 6.9 days for each 1% rise in GHb. The reticulocyte count inversely correlated with erythrocyte life span (r = -0.77, P < 0.01). CONCLUSIONS: Hyperglycemia, as evidenced by high GHb percentage, is associated with an appreciable decrease in erythrocyte life span. Because GHb appears to be formed over the lifetime of the erythrocyte, this decreased erythrocyte survival suggests that high GHb percentages may systematically underestimate the true degree of hyperglycemia.
OBJECTIVE: Subjects with decreased erythrocyte survival have an unusually low GHb percentage. The goal of this study was to determine whether hyperglycemia, as reflected by GHb percentage, is associated with decreased erythrocyte survival. RESEARCH DESIGN AND METHODS: Erythrocyte survival was quantitated in 23 subjects with type 2 diabetes, and these values were correlated with the subjects' GHb percentage. Erythrocyte survival was determined from the difference between the subjects' alveolar carbon monoxide (CO) concentration and atmospheric CO concentration. Reticulocyte counts were obtained in 16 subjects. RESULTS: Although the vast majority of the subjects had erythrocyte life spans that fell within the normal range (123 +/- 23 days), there was a highly significant inverse correlation (r = -0.66, P < 0.01) between life span and GHb percentage, with an average decline in life span of 6.9 days for each 1% rise in GHb. The reticulocyte count inversely correlated with erythrocyte life span (r = -0.77, P < 0.01). CONCLUSIONS:Hyperglycemia, as evidenced by high GHb percentage, is associated with an appreciable decrease in erythrocyte life span. Because GHb appears to be formed over the lifetime of the erythrocyte, this decreased erythrocyte survival suggests that high GHb percentages may systematically underestimate the true degree of hyperglycemia.
Authors: Kylie Kavanagh; David M Flynn; Chris Nelson; Li Zhang; Janice D Wagner Journal: J Pharmacol Toxicol Methods Date: 2011-02-26 Impact factor: 1.950
Authors: Paramjit K Khera; Eric P Smith; Christopher J Lindsell; Mary Colleen Rogge; Shannon Haggerty; David A Wagner; Mary B Palascak; Shilpa Mehta; Jacqueline M Hibbert; Clinton H Joiner; Robert S Franco; Robert M Cohen Journal: Am J Hematol Date: 2015-01 Impact factor: 10.047
Authors: Robert M Cohen; Robert S Franco; Paramjit K Khera; Eric P Smith; Christopher J Lindsell; Peter J Ciraolo; Mary B Palascak; Clinton H Joiner Journal: Blood Date: 2008-08-11 Impact factor: 22.113
Authors: William H Herman; Yong Ma; Gabriel Uwaifo; Steven Haffner; Steven E Kahn; Edward S Horton; John M Lachin; Maria G Montez; Tina Brenneman; Elizabeth Barrett-Connor Journal: Diabetes Care Date: 2007-05-29 Impact factor: 19.112